Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-01-01 @ 12:16 AM
Study NCT ID:
NCT06980805
Status:
RECRUITING
Last Update Posted:
2025-11-06
First Post:
2025-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
Sponsor:
Immunovant Sciences GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-08
First Submit QC Date:
None
Study First Post Date:
2025-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-05
Last Update Post Date:
2025-11-06
Last Update Post Date Type:
ESTIMATED